ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Imago Biosciences Ltd

Imago Biosciences Ltd is a dissolved company incorporated on 8 November 2013 with the registered office located in London, City of London. Imago Biosciences Ltd was registered 11 years ago.
Status
Dissolved
Dissolved on 31 December 2024 (8 months ago)
Was 11 years old at the time of dissolution
Via voluntary strike-off
Company No
08767200
Private limited company
Age
11 years
Incorporated 8 November 2013
Size
Micro
Turnover is under £1M
Balance sheet is under £500,000
Under 10 employees
Confirmation
Submitted
Dated 8 November 2023 (1 year 10 months ago)
Next confirmation dated 1 January 1970
Last change occurred 1 year 9 months ago
Accounts
Not Submitted
Awaiting first accounts
Contact
Address
120 Moorgate
London
EC2M 6UR
England
Address changed on 7 Feb 2023 (2 years 7 months ago)
Previous address was The Bryn the Bryn Redwick Magor Caldicot NP26 3DE United Kingdom
Telephone
Unreported
Email
Unreported
Website
People
Officers
4
Shareholders
1
Controllers (PSC)
1
Director • British • Lives in UK • Born in Nov 1974
Director • British • Lives in England • Born in Oct 1981
Director • British • Lives in UK • Born in Jul 1980
Director • Turkish • Lives in UK • Born in Oct 1972
PSC
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Merck Sharp & Dohme (UK) Limited
Benjamin Paul Lucas, Ebru Can Temucin, and 1 more are mutual people.
Active
Schering-Plough Holdings Limited
Benjamin Paul Lucas, Ebru Can Temucin, and 1 more are mutual people.
Active
MSD Limited
Benjamin Paul Lucas, Ebru Can Temucin, and 1 more are mutual people.
Active
MSD R&D Innovation Centre Limited
Benjamin Paul Lucas and Ebru Can Temucin are mutual people.
Active
Merck Sharp & Dohme Finance Europe Limited
Benjamin Paul Lucas and Ebru Can Temucin are mutual people.
Active
Eyebiotech Limited
Benjamin Paul Lucas is a mutual person.
Active
Iomet Pharma Ltd
Ebru Can Temucin is a mutual person.
Active
Financials
Net Assets, Total Assets & Total Liabilities (2014–2022)
Period Ended
31 Dec 2022
For period 1 Dec31 Dec 2022
Traded for 13 months
Cash in Bank
£1K
Same as previous period
Turnover
Unreported
Same as previous period
Employees
Unreported
Same as previous period
Total Assets
£1K
Same as previous period
Total Liabilities
£0
Same as previous period
Net Assets
£1K
Same as previous period
Debt Ratio (%)
0%
Same as previous period
Latest Activity
Voluntarily Dissolution
8 Months Ago on 31 Dec 2024
Voluntary Gazette Notice
10 Months Ago on 15 Oct 2024
Application To Strike Off
11 Months Ago on 2 Oct 2024
Samuel Robert Pygall Resigned
1 Year 9 Months Ago on 28 Nov 2023
John Reilly Mcneill Appointed
1 Year 9 Months Ago on 28 Nov 2023
Confirmation Submitted
1 Year 9 Months Ago on 13 Nov 2023
Dormant Accounts Submitted
1 Year 11 Months Ago on 27 Sep 2023
Accounting Period Extended
2 Years 5 Months Ago on 30 Mar 2023
Ebru Can Temucin Appointed
2 Years 5 Months Ago on 20 Mar 2023
Benjamin Paul Lucas Appointed
2 Years 5 Months Ago on 20 Mar 2023
Get Credit Report
Discover Imago Biosciences Ltd's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Final Gazette dissolved via voluntary strike-off
Submitted on 31 Dec 2024
First Gazette notice for voluntary strike-off
Submitted on 15 Oct 2024
Application to strike the company off the register
Submitted on 2 Oct 2024
Termination of appointment of Samuel Robert Pygall as a director on 28 November 2023
Submitted on 3 Sep 2024
Appointment of John Reilly Mcneill as a director on 28 November 2023
Submitted on 4 Dec 2023
Termination of appointment of a director
Submitted on 30 Nov 2023
Confirmation statement made on 8 November 2023 with updates
Submitted on 13 Nov 2023
Accounts for a dormant company made up to 31 December 2022
Submitted on 27 Sep 2023
Appointment of Benjamin Paul Lucas as a director on 20 March 2023
Submitted on 31 Mar 2023
Appointment of Ebru Can Temucin as a director on 20 March 2023
Submitted on 31 Mar 2023
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year